{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:37:50Z","timestamp":1767677870970,"version":"3.48.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Opening Fund of Jiangxi Health Commission Key Laboratory of Leukemia","award":["2025-001"],"award-info":[{"award-number":["2025-001"]}]},{"name":"Science and Technology Plan Fund of Jiangxi Provincial Administration of Traditional Chinese Medicine","award":["2023A0351"],"award-info":[{"award-number":["2023A0351"]}]},{"name":"Science and Technology Research Project of Jiangxi Provincial Department of Education","award":["GJJ2401318"],"award-info":[{"award-number":["GJJ2401318"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01975-7","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T15:03:44Z","timestamp":1765119824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA NEAT1 restrains the malignant biological characteristics of acute myeloid leukemia via regulating CTCF\/CXCR2 axis"],"prefix":"10.1007","volume":"26","author":[{"given":"Yanquan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuotao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hehui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanwen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"issue":"1","key":"1975_CR1","doi-asserted-by":"publisher","first-page":"17874","DOI":"10.1038\/s41598-024-68755-3","volume":"14","author":"Y Qin","year":"2024","unstructured":"Qin Y, Pu X, Hu D, Yang M. Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns. Sci Rep. 2024;14(1):17874. https:\/\/doi.org\/10.1038\/s41598-024-68755-3.","journal-title":"Sci Rep"},{"issue":"11","key":"1975_CR2","doi-asserted-by":"publisher","first-page":"e7376","DOI":"10.1002\/cam4.7376","volume":"13","author":"Y Solomon","year":"2024","unstructured":"Solomon Y, Berhan A, Almaw A, et al. Long non-coding RNA as potential diagnostic markers for acute myeloid leukemia: A systematic review and meta-analysis. Cancer Med. 2024;13(11):e7376. https:\/\/doi.org\/10.1002\/cam4.7376.","journal-title":"Cancer Med"},{"issue":"10","key":"1975_CR3","doi-asserted-by":"publisher","first-page":"e0292172","DOI":"10.1371\/journal.pone.0292172","volume":"18","author":"M Ilyas","year":"2023","unstructured":"Ilyas M, Aamir KM, Manzoor S, et al. Linear programming based computational technique for leukemia classification using gene expression profile. PLoS ONE. 2023;18(10):e0292172. https:\/\/doi.org\/10.1371\/journal.pone.0292172.","journal-title":"PLoS ONE"},{"issue":"1","key":"1975_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40364-024-00649-y","volume":"12","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Huang G, Cai X, Liu Y, Qian B, Li D. Global, regional, and National burden of acute myeloid leukemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Biomark Res. 2024;12(1):101. https:\/\/doi.org\/10.1186\/s40364-024-00649-y.","journal-title":"Biomark Res"},{"issue":"1","key":"1975_CR5","doi-asserted-by":"publisher","first-page":"e53303","DOI":"10.7759\/cureus.53303","volume":"16","author":"A Iqbal","year":"2024","unstructured":"Iqbal A, Dubey M, Randhawa AS, et al. Improved treatment outcomes with modified induction therapy in acute myeloid leukemia (AML): A retrospective observational study from a regional cancer center. Cureus. 2024;16(1):e53303. https:\/\/doi.org\/10.7759\/cureus.53303.","journal-title":"Cureus"},{"issue":"24","key":"1975_CR6","doi-asserted-by":"publisher","first-page":"21592","DOI":"10.1002\/cam4.6693","volume":"12","author":"Y Zhai","year":"2023","unstructured":"Zhai Y, Wang Q, Ji L, et al. Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world. Cancer Med. 2023;12(24):21592\u2013604. https:\/\/doi.org\/10.1002\/cam4.6693.","journal-title":"Cancer Med"},{"key":"1975_CR7","doi-asserted-by":"publisher","first-page":"1348894","DOI":"10.3389\/fcell.2024.1348894","volume":"12","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Tang JM, Yang MQ, et al. The role of LncRNA-mediated autophagy in cancer progression. Front Cell Dev Biol. 2024;12:1348894. https:\/\/doi.org\/10.3389\/fcell.2024.1348894.","journal-title":"Front Cell Dev Biol"},{"key":"1975_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3389\/fonc.2020.00941","volume":"10","author":"X Peng","year":"2020","unstructured":"Peng X, Zhang K, Ma L, et al. The role of long Non-Coding RNAs in thyroid cancer. Front Oncol. 2020;10:941. https:\/\/doi.org\/10.3389\/fonc.2020.00941.","journal-title":"Front Oncol"},{"issue":"11","key":"1975_CR9","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/life12111770","volume":"12","author":"V Gasic","year":"2022","unstructured":"Gasic V, Karan-Djurasevic T, Pavlovic D, Zukic B, Pavlovic S, Tosic N. Diagnostic and therapeutic implications of long Non-Coding RNAs in leukemia. Life (Basel). 2022;12(11):1770. https:\/\/doi.org\/10.3390\/life12111770.","journal-title":"Life (Basel)"},{"key":"1975_CR10","doi-asserted-by":"publisher","first-page":"103849","DOI":"10.1016\/j.critrevonc.2022.103849","volume":"180","author":"X Guan","year":"2022","unstructured":"Guan X, Sun Y, Zhang C. LncRNAs in blood cells: roles in cell development and potential pathogenesis in hematological malignancies. Crit Rev Oncol Hematol. 2022;180:103849. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103849.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"18","key":"1975_CR11","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.3390\/cancers14184388","volume":"14","author":"NE Smith","year":"2022","unstructured":"Smith NE, Spencer-Merris P, Fox AH, Petersen J, Michael MZ. The long and the short of it: NEAT1 and cancer cell metabolism. Cancers (Basel). 2022;14(18):4388. https:\/\/doi.org\/10.3390\/cancers14184388.","journal-title":"Cancers (Basel)"},{"issue":"36","key":"1975_CR12","doi-asserted-by":"publisher","first-page":"26067","DOI":"10.1074\/jbc.M113.486175","volume":"288","author":"K Huang","year":"2013","unstructured":"Huang K, Jia J, Wu C, et al. Ribosomal RNA gene transcription mediated by the master genome regulator protein CCCTC-binding factor (CTCF) is negatively regulated by the condensin complex. J Biol Chem. 2013;288(36):26067\u201377. https:\/\/doi.org\/10.1074\/jbc.M113.486175.","journal-title":"J Biol Chem"},{"issue":"23","key":"1975_CR13","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1182\/blood.2021011992","volume":"138","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Xu M, Huang S. Long noncoding rnas: emerging regulators of normal and malignant hematopoiesis. Blood. 2021;138(23):2327\u201336. https:\/\/doi.org\/10.1182\/blood.2021011992.","journal-title":"Blood"},{"issue":"6","key":"1975_CR14","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s12015-020-10057-y","volume":"16","author":"J Zha","year":"2020","unstructured":"Zha J, Lai Q, Deng M, Shi P, Zhao H, Chen Q, Wu H, Xu B. Disruption of CTCF boundary at HOXA locus promote BET inhibitors\u2019 therapeutic sensitivity in acute myeloid leukemia. Stem Cell Rev Rep. 2020;16(6):1280\u201391. https:\/\/doi.org\/10.1007\/s12015-020-10057-y.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"1975_CR15","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1038\/s41467-024-49811-y","volume":"15","author":"R Mulet-Lazaro","year":"2024","unstructured":"Mulet-Lazaro R, van Herk S, Nuetzel M, Sijs-Szabo A, D\u00edaz N, Kelly K, Erpelinck-Verschueren C, Schwarzfischer-Pfeilschifter L, Stanewsky H, Ackermann U, Glatz D, Raithel J, Fischer A, Pohl S, Rijneveld A, Vaquerizas JM, Thiede C, Plass C, Wouters BJ, Delwel R, Rehli M, Gebhard C. Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid\/lymphoid leukemia. Nat Commun. 2024;15(1):5693. https:\/\/doi.org\/10.1038\/s41467-024-49811-y.","journal-title":"Nat Commun"},{"issue":"1","key":"1975_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/cancers15010167","volume":"15","author":"T Wu","year":"2022","unstructured":"Wu T, Yang W, Sun A, et al. The role of CXC chemokines in cancer progression. Cancers (Basel). 2022;15(1):167. https:\/\/doi.org\/10.3390\/cancers15010167.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1975_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3969\/j.issn.2095-5227.2023.03.002","volume":"44","author":"YQ Liu","year":"2023","unstructured":"Liu YQ, Zeng MJ, Yin Y, et al. Abnormal expression and clinical significance of CXC chemokine receptor 1\/2 in acute leukemia. Acad J Chin PLA Med Sch. 2023;44(3):213\u20139. https:\/\/doi.org\/10.3969\/j.issn.2095-5227.2023.03.002.","journal-title":"Acad J Chin PLA Med Sch"},{"issue":"2","key":"1975_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.19746\/j.cnki.issn.1009-2137.2023.02.009","volume":"31","author":"YQ Liu","year":"2023","unstructured":"Liu YQ, Shen JZ, Yin Y, et al. The effects and regulatory mechanism of targeting CXC chemokine receptor 1\/2 combined with Ara-C on the malignant biological behaviors of U937 cells of acute myeloid leukemia. J Exp Hematol. 2023;31(2):364\u201376. https:\/\/doi.org\/10.19746\/j.cnki.issn.1009-2137.2023.02.009.","journal-title":"J Exp Hematol"},{"issue":"20","key":"1975_CR19","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","journal-title":"Blood"},{"issue":"18","key":"1975_CR20","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1080\/15384101.2022.2075198","volume":"21","author":"J Geng","year":"2022","unstructured":"Geng J, Cui C, Yin Y, Zhao Y, Zhang C. LncRNA NEAT1 affects endometrial receptivity by regulating HOXA10 promoter activity. Cell Cycle. 2022;21(18):1932\u201344. https:\/\/doi.org\/10.1080\/15384101.2022.2075198.","journal-title":"Cell Cycle"},{"issue":"8","key":"1975_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/kjm2.12843","volume":"40","author":"DB Ma","year":"2024","unstructured":"Ma DB, Zhang H, Wang XL, Wu QG. METTL3 aggravates cell damage induced by Streptococcus pneumoniae via the NEAT1\/CTCF\/MUC19 axis. Kaohsiung J Med Sci. 2024;40(8):722\u201331. https:\/\/doi.org\/10.1002\/kjm2.12843.","journal-title":"Kaohsiung J Med Sci"},{"key":"1975_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.molimm.2019.10.009","volume":"117","author":"D Xia","year":"2020","unstructured":"Xia D, Yao R, Zhou P, et al. LncRNA NEAT1 reversed the hindering effects of miR-495-3p\/STAT3 axis and miR-211\/PI3K\/AKT axis on sepsis-relevant inflammation. Mol Immunol. 2020;117:168\u201379. https:\/\/doi.org\/10.1016\/j.molimm.2019.10.009.","journal-title":"Mol Immunol"},{"issue":"11","key":"1975_CR23","doi-asserted-by":"publisher","first-page":"e22091","DOI":"10.1016\/j.heliyon.2023.e22091","volume":"9","author":"JH Kim","year":"2023","unstructured":"Kim JH, Kang KW, Park Y, et al. CXCR2 Inhibition overcomes Ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K\/Akt\/mTOR and dipeptidylpeptidase \u2163 (CD26). Heliyon. 2023;9(11):e22091. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22091.","journal-title":"Heliyon"},{"issue":"4","key":"1975_CR24","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1096\/fj.201801931R","volume":"33","author":"J Cheng","year":"2019","unstructured":"Cheng J, Li Y, Liu S, et al. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K\/AKT pathway. FASEB J. 2019;33(4):4755\u201364. https:\/\/doi.org\/10.1096\/fj.201801931R.","journal-title":"FASEB J"},{"issue":"7","key":"1975_CR25","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3324\/haematol.2023.284921","volume":"109","author":"G Vermeersch","year":"2024","unstructured":"Vermeersch G, Proost P, Struyf S, et al. CXCL8 and its cognate receptors CXCR1\/CXCR2 in primary myelofibrosis. Haematologica. 2024;109(7):2060\u201372. https:\/\/doi.org\/10.3324\/haematol.2023.284921.","journal-title":"Haematologica"},{"issue":"13","key":"1975_CR26","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3390\/cancers16132474","volume":"16","author":"I Konstantinidis","year":"2024","unstructured":"Konstantinidis I, Tsokkou S, Grigoriadis S, et al. Cardiotoxicity in acute myeloid leukemia in adults: A scoping study. Cancers (Basel). 2024;16(13):2474. https:\/\/doi.org\/10.3390\/cancers16132474.","journal-title":"Cancers (Basel)"},{"key":"1975_CR27","doi-asserted-by":"publisher","first-page":"115539","DOI":"10.1016\/j.bcp.2023.115539","volume":"212","author":"Q Li","year":"2023","unstructured":"Li Q, Wang M, Liu L. The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia. Biochem Pharmacol. 2023;212:115539. https:\/\/doi.org\/10.1016\/j.bcp.2023.115539.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1975_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.19746\/j.cnki.issn.1009-2137.2023.04.009","volume":"31","author":"YQ Liu","year":"2023","unstructured":"Liu YQ, Yin Y, Zeng MJ, et al. The mechanisms of Piceatannol in inhibiting the malignant biological characteristics of acute myeloid leukemia cells. J Exp Hematol. 2023;31(4):985\u201391. https:\/\/doi.org\/10.19746\/j.cnki.issn.1009-2137.2023.04.009.","journal-title":"J Exp Hematol"},{"issue":"12","key":"1975_CR29","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/cncr.29319","volume":"121","author":"ME Percival","year":"2015","unstructured":"Percival ME, Tao L, Medeiros BC, Clarke CA. Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis. Cancer. 2015;121(12):2004\u201312. https:\/\/doi.org\/10.1002\/cncr.29319.","journal-title":"Cancer"},{"issue":"10","key":"1975_CR30","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/j.1537-2995.2007.01406.x","volume":"47","author":"G Bug","year":"2007","unstructured":"Bug G, Anargyrou K, Tonn T, et al. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion. 2007;47(10):1843\u201350. https:\/\/doi.org\/10.1111\/j.1537-2995.2007.01406.x.","journal-title":"Transfusion"},{"issue":"14","key":"1975_CR31","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.3390\/ijms25147916","volume":"25","author":"A Kowalczyk","year":"2024","unstructured":"Kowalczyk A, Zarychta J, Lejman M, Latoch E, Zawitkowska J. Clinical implications of isocitrate dehydrogenase mutations and targeted treatment of acute myeloid leukemia with mutant isocitrate dehydrogenase Inhibitors-Recent Advances, challenges and future prospects. Int J Mol Sci. 2024;25(14):7916. https:\/\/doi.org\/10.3390\/ijms25147916.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1975_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/10428194.2023.2292473","volume":"65","author":"D Ngo","year":"2024","unstructured":"Ngo D, Tinajero J, Li S, et al. Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib. Leuk Lymphoma. 2024;65(3):372\u20137. https:\/\/doi.org\/10.1080\/10428194.2023.2292473.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1975_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.20517\/cdr.2023.39","volume":"6","author":"L Gurska","year":"2023","unstructured":"Gurska L, Gritsman K. Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia. Cancer Drug Resist. 2023;6(3):674\u201387. https:\/\/doi.org\/10.20517\/cdr.2023.39.","journal-title":"Cancer Drug Resist"},{"key":"1975_CR34","doi-asserted-by":"publisher","first-page":"1389154","DOI":"10.3389\/fpls.2024.1389154","volume":"15","author":"A Zhang","year":"2024","unstructured":"Zhang A, Pi W, Wang Y, et al. Update on functional analysis of long non-coding RNAs in common crops. Front Plant Sci. 2024;15:1389154. https:\/\/doi.org\/10.3389\/fpls.2024.1389154.","journal-title":"Front Plant Sci"},{"key":"1975_CR35","doi-asserted-by":"publisher","first-page":"102866","DOI":"10.1016\/j.sbi.2024.102866","volume":"87","author":"S Han","year":"2024","unstructured":"Han S, Chen LL. Long non-coding RNAs in the nucleolus: Biogenesis, regulation, and function. Curr Opin Struct Biol. 2024;87:102866. https:\/\/doi.org\/10.1016\/j.sbi.2024.102866.","journal-title":"Curr Opin Struct Biol"},{"key":"1975_CR36","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/DDDT.S448707","volume":"18","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wu L, Wang C, Xie X, Han Y. Research progress of long Non-Coding RNA in tumor drug resistance: A new paradigm. Drug Des Devel Ther. 2024;18:1385\u201398. https:\/\/doi.org\/10.2147\/DDDT.S448707.","journal-title":"Drug Des Devel Ther"},{"key":"1975_CR37","doi-asserted-by":"publisher","first-page":"155252","DOI":"10.1016\/j.prp.2024.155252","volume":"256","author":"RU Syed","year":"2024","unstructured":"Syed RU, Afsar S, Aboshouk NAM, et al. LncRNAs in necroptosis: Deciphering their role in cancer pathogenesis and therapy. Pathol Res Pract. 2024;256:155252. https:\/\/doi.org\/10.1016\/j.prp.2024.155252.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"1975_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41416-021-01588-3","volume":"126","author":"E Knutsen","year":"2022","unstructured":"Knutsen E, Harris AL, Perander M. Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer. Br J Cancer. 2022;126(4):551\u201361. https:\/\/doi.org\/10.1038\/s41416-021-01588-3.","journal-title":"Br J Cancer"},{"issue":"28","key":"1975_CR39","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2174\/0113816128257113230921035222","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wen Y. The role of LncRNA NEAT1 in gastric cancer: tumor development and potential therapeutic target. Curr Pharm Des. 2023;29(28):2213\u201322. https:\/\/doi.org\/10.2174\/0113816128257113230921035222.","journal-title":"Curr Pharm Des"},{"key":"1975_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.17179\/excli2023-6553","volume":"23","author":"MS Hussain","year":"2024","unstructured":"Hussain MS, Afzal O, Gupta G, et al. Unraveling NEAT1\u2019s complex role in lung cancer biology: a comprehensive review. EXCLI J. 2024;23:34\u201352. https:\/\/doi.org\/10.17179\/excli2023-6553.","journal-title":"EXCLI J"},{"issue":"6","key":"1975_CR41","doi-asserted-by":"publisher","first-page":"9831","DOI":"10.1002\/jcb.28263","volume":"120","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wu K, Wu J, et al. NEAT1 is a potential prognostic biomarker for patients with nasopharyngeal carcinoma. J Cell Biochem. 2019;120(6):9831\u20138. https:\/\/doi.org\/10.1002\/jcb.28263.","journal-title":"J Cell Biochem"},{"issue":"6","key":"1975_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000515228","volume":"83","author":"P Wang","year":"2021","unstructured":"Wang P, Li QY, Sun YN, Wang JT, Liu M, Long Noncoding. RNA NEAT1: A potential biomarker in the progression of laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2021;83(6):464\u201370. https:\/\/doi.org\/10.1159\/000515228.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"1","key":"1975_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12967-022-03273-2","volume":"20","author":"J Liang","year":"2022","unstructured":"Liang J, Liu C, Xu D, Xie K, Li A. LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1. J Transl Med. 2022;20(1):80. https:\/\/doi.org\/10.1186\/s12967-022-03273-2.","journal-title":"J Transl Med"},{"issue":"5","key":"1975_CR44","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.7150\/jca.91896","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu G. Targeting NEAT1 affects the sensitivity to PARPi in serous ovarian cancer by regulating the homologous recombination repair pathway. J Cancer. 2024;15(5):1397\u2013413. https:\/\/doi.org\/10.7150\/jca.91896.","journal-title":"J Cancer"},{"issue":"2","key":"1975_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10616-023-00612-z","volume":"76","author":"W Xu","year":"2024","unstructured":"Xu W, Wu Y, Zhang G. NEAT1 promotes the progression of prostate cancer by targeting the miR-582-5p\/EZH2 regulatory axis. Cytotechnology. 2024;76(2):231\u201346. https:\/\/doi.org\/10.1007\/s10616-023-00612-z.","journal-title":"Cytotechnology"},{"issue":"1","key":"1975_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12935-024-03426-x","volume":"24","author":"F Long","year":"2024","unstructured":"Long F, Li X, Pan J, et al. The role of LncRNA NEAT1 in human cancer chemoresistance. Cancer Cell Int. 2024;24(1):236. https:\/\/doi.org\/10.1186\/s12935-024-03426-x.","journal-title":"Cancer Cell Int"},{"key":"1975_CR47","doi-asserted-by":"publisher","first-page":"106807","DOI":"10.1016\/j.leukres.2022.106807","volume":"115","author":"M Rostami","year":"2022","unstructured":"Rostami M, Kharajo RS, Parsa-Kondelaji M, Ayatollahi H, Sheikhi M, Keramati MR. Altered expression of NEAT1 variants and P53, PTEN, and BCL-2 genes in patients with acute myeloid leukemia. Leuk Res. 2022;115:106807. https:\/\/doi.org\/10.1016\/j.leukres.2022.106807.","journal-title":"Leuk Res"},{"issue":"22","key":"1975_CR48","doi-asserted-by":"publisher","first-page":"e2100914","DOI":"10.1002\/advs.202100914","volume":"8","author":"H Yan","year":"2021","unstructured":"Yan H, Wang Z, Sun Y, Hu L, Bu P. Cytoplasmic NEAT1 suppresses AML stem cell Self-Renewal and leukemogenesis through inactivation of Wnt signaling. Adv Sci (Weinh). 2021;8(22):e2100914. https:\/\/doi.org\/10.1002\/advs.202100914.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"1975_CR49","doi-asserted-by":"publisher","first-page":"109576","DOI":"10.1016\/j.celrep.2021.109576","volume":"36","author":"K Yamamoto","year":"2021","unstructured":"Yamamoto K, Goyama S, Asada S, Fujino T, Yonezawa T, Sato N, Takeda R, Tsuchiya A, Fukuyama T, Tanaka Y, Yokoyama A, Toya H, Kon A, Nannya Y, Onoguchi-Mizutani R, Nakagawa S, Hirose T, Ogawa S, Akimitsu N, Kitamura T. A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells. Cell Rep. 2021;36(8):109576. https:\/\/doi.org\/10.1016\/j.celrep.2021.109576.","journal-title":"Cell Rep"},{"issue":"2","key":"1975_CR50","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3892\/ol.2020.11700","volume":"20","author":"G Li","year":"2020","unstructured":"Li G, Gao Y, Li K, Lin A, Jiang Z. Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia. Oncol Lett. 2020;20(2):1824\u201334. https:\/\/doi.org\/10.3892\/ol.2020.11700.","journal-title":"Oncol Lett"},{"issue":"7","key":"1975_CR51","doi-asserted-by":"publisher","first-page":"114367","DOI":"10.1016\/j.celrep.2024.114367","volume":"43","author":"P Kakani","year":"2024","unstructured":"Kakani P, Dhamdhere SG, Pant D, et al. Hypoxia-induced CTCF promotes EMT in breast cancer. Cell Rep. 2024;43(7):114367. https:\/\/doi.org\/10.1016\/j.celrep.2024.114367.","journal-title":"Cell Rep"},{"issue":"16","key":"1975_CR52","doi-asserted-by":"publisher","first-page":"16270","DOI":"10.18632\/aging.103648","volume":"12","author":"Q Lai","year":"2020","unstructured":"Lai Q, Li Q, He C, et al. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis. Aging. 2020;12(16):16270\u201393. https:\/\/doi.org\/10.18632\/aging.103648.","journal-title":"Aging"},{"issue":"12","key":"1975_CR53","doi-asserted-by":"publisher","first-page":"e22584","DOI":"10.1016\/j.heliyon.2023.e22584","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Qi W, Yin J, et al. High CTCF expression mediated by FGD5-AS1\/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression. Heliyon. 2023;9(12):e22584. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22584.","journal-title":"Heliyon"},{"issue":"37","key":"1975_CR54","doi-asserted-by":"publisher","first-page":"62217","DOI":"10.18632\/oncotarget.19216","volume":"8","author":"L Zhao","year":"2017","unstructured":"Zhao L, Yang Y, Yin S, et al. CTCF promotes epithelial ovarian cancer metastasis by broadly controlling the expression of metastasis-associated genes. Oncotarget. 2017;8(37):62217\u201330. https:\/\/doi.org\/10.18632\/oncotarget.19216.","journal-title":"Oncotarget"},{"issue":"20","key":"1975_CR55","doi-asserted-by":"publisher","first-page":"e107795","DOI":"10.15252\/embj.2021107795","volume":"40","author":"S Sivapragasam","year":"2021","unstructured":"Sivapragasam S, Stark B, Albrecht AV, et al. CTCF binding modulates UV damage formation to promote mutation hot spots in melanoma. EMBO J. 2021;40(20):e107795. https:\/\/doi.org\/10.15252\/embj.2021107795.","journal-title":"EMBO J"},{"key":"1975_CR56","doi-asserted-by":"publisher","first-page":"584766","DOI":"10.3389\/fonc.2020.584766","volume":"10","author":"C Lu","year":"2020","unstructured":"Lu C, Zhu J, Chen X, et al. Risk stratification in acute myeloid leukemia using CXCR gene signatures: A bioinformatics analysis. Front Oncol. 2020;10:584766. https:\/\/doi.org\/10.3389\/fonc.2020.584766.","journal-title":"Front Oncol"},{"issue":"18","key":"1975_CR57","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.3390\/cancers15184555","volume":"15","author":"J Korbecki","year":"2023","unstructured":"Korbecki J, Kupnicka P, Barczak K, et al. The role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 ligands in molecular cancer processes and clinical aspects of acute myeloid leukemia (AML). Cancers (Basel). 2023;15(18):4555. https:\/\/doi.org\/10.3390\/cancers15184555.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1975_CR58","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1182\/blood-2004-02-0566","volume":"104","author":"EJ Rombouts","year":"2004","unstructured":"Rombouts EJ, Pavic B, L\u00f6wenberg B, Ploemacher RE. Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood. 2004;104(2):550\u20137. https:\/\/doi.org\/10.1182\/blood-2004-02-0566.","journal-title":"Blood"},{"issue":"7","key":"1975_CR59","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1021\/acs.biomac.4c00561","volume":"25","author":"J Yang","year":"2024","unstructured":"Yang J, Zhang P, Mao Y, et al. CXCR4-Mediated codelivery of FLT3 and BCL-2 inhibitors for enhanced targeted combination therapy of FLT3-ITD acute myeloid leukemia. Biomacromolecules. 2024;25(7):4569\u201380. https:\/\/doi.org\/10.1021\/acs.biomac.4c00561.","journal-title":"Biomacromolecules"},{"issue":"6","key":"1975_CR60","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41375-023-01897-x","volume":"37","author":"Y Jia","year":"2023","unstructured":"Jia Y, Zhang W, Basyal M, et al. FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4\/E-selectin Inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML. Leukemia. 2023;37(6):1379\u201383. https:\/\/doi.org\/10.1038\/s41375-023-01897-x.","journal-title":"Leukemia"},{"issue":"5","key":"1975_CR61","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/biomedicines10051038","volume":"10","author":"H Cao","year":"2022","unstructured":"Cao H, Tadros V, Hiramoto B, et al. Targeting TKI-Activated NFKB2-MIF\/CXCLs-CXCR2 signaling pathways in FLT3 mutated acute myeloid leukemia reduced blast viability. Biomedicines. 2022;10(5):1038. https:\/\/doi.org\/10.3390\/biomedicines10051038.","journal-title":"Biomedicines"},{"issue":"20","key":"1975_CR62","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1182\/blood-2015-01-621631","volume":"125","author":"C Schinke","year":"2015","unstructured":"Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway Inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144\u201352. https:\/\/doi.org\/10.1182\/blood-2015-01-621631.","journal-title":"Blood"},{"issue":"11","key":"1975_CR63","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/gt.2017.88","volume":"24","author":"M T\u00e4ger","year":"2017","unstructured":"T\u00e4ger M, Horn S, Latuske E, et al. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model. Gene Ther. 2017;24(11):749\u201353. https:\/\/doi.org\/10.1038\/gt.2017.88.","journal-title":"Gene Ther"},{"issue":"2","key":"1975_CR64","doi-asserted-by":"publisher","first-page":"103429","DOI":"10.1016\/j.retram.2023.103429","volume":"72","author":"M Gorji","year":"2024","unstructured":"Gorji M, Farsani MA, Kargar M, Garavand J, Mohammadi MH. Investigating the multifaceted Cooperation of autophagy, PI3K\/AKT signaling pathways, and INPP4B gene in de Novo acute myeloid leukemia patients. Curr Res Transl Med. 2024;72(2):103429. https:\/\/doi.org\/10.1016\/j.retram.2023.103429.","journal-title":"Curr Res Transl Med"},{"issue":"4","key":"1975_CR65","doi-asserted-by":"publisher","first-page":"984","DOI":"10.20517\/cdr.2021.76","volume":"4","author":"M Estruch","year":"2021","unstructured":"Estruch M, Vittori C, Montesinos TM, Reckzeh K, Theilgaard-M\u00f6nch K. Targeting of PI3K\/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance. Cancer Drug Resist. 2021;4(4):984\u201395. https:\/\/doi.org\/10.20517\/cdr.2021.76.","journal-title":"Cancer Drug Resist"},{"issue":"19","key":"1975_CR66","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood.2023022202","volume":"143","author":"H Gu","year":"2024","unstructured":"Gu H, Chen C, Hou ZS, et al. PI3K\u03b3 maintains the self-renewal of acute myeloid leukemia stem cells by regulating the Pentose phosphate pathway. Blood. 2024;143(19):1965\u201379. https:\/\/doi.org\/10.1182\/blood.2023022202.","journal-title":"Blood"},{"key":"1975_CR67","doi-asserted-by":"publisher","first-page":"112436","DOI":"10.1016\/j.exger.2024.112436","volume":"191","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li Z, Li J, Sun C. LncRNA NEAT1 promotes MPP\u2009+\u2009induced injury of PC12 cells and accelerates the progression of parkinson\u2019s disease in mice through FUS mediated Inhibition of PI3K\/AKT\/mTOR signalling pathway. Exp Gerontol. 2024;191:112436. https:\/\/doi.org\/10.1016\/j.exger.2024.112436.","journal-title":"Exp Gerontol"},{"issue":"5","key":"1975_CR68","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/kjm2.12354","volume":"37","author":"O Li","year":"2021","unstructured":"Li O, Jiang B, Yi WM, et al. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p\/PTP4A1 axis in cholangiocarcinoma. Kaohsiung J Med Sci. 2021;37(5):379\u201391. https:\/\/doi.org\/10.1002\/kjm2.12354.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"1975_CR69","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1515\/med-2020-0218","volume":"15","author":"D Wu","year":"2020","unstructured":"Wu D, Li H, Wang J, et al. LncRNA NEAT1 promotes gastric cancer progression via miR-1294\/AKT1 axis. Open Med (Wars). 2020;15(1):1028\u201338. https:\/\/doi.org\/10.1515\/med-2020-0218.","journal-title":"Open Med (Wars)"},{"issue":"19","key":"1975_CR70","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.26355\/eurrev_201810_16053","volume":"22","author":"H Xu","year":"2018","unstructured":"Xu H, Li J, Zhou ZG. NEAT1 promotes cell proliferation in multiple myeloma by activating PI3K\/AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22(19):6403\u201311. https:\/\/doi.org\/10.26355\/eurrev_201810_16053.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"1975_CR71","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.medcli.2018.08.006","volume":"152","author":"FM Shang","year":"2019","unstructured":"Shang FM, Li J. A small-molecule antagonist of CXCR1 and CXCR2 inhibits cell proliferation, migration and invasion in melanoma via PI3K\/AKT pathway. Med Clin (Barc). 2019;152(11):425\u201330. https:\/\/doi.org\/10.1016\/j.medcli.2018.08.006.","journal-title":"Med Clin (Barc)"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01975-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:31:55Z","timestamp":1767677515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01975-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1975"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01975-7","relation":{},"ISSN":["1591-9528"],"issn-type":[{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Gannan Medical University and Fujian Medical University Union Hospital (approval number: LLSC-2023247 and 2019KY092, respectively).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"93"}}